BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 26330008)

  • 21. Long-term outcome of re-irradiation for recurrent or second primary head and neck cancer: A multi-institutional study of AIRO-Head and Neck working group.
    Orlandi E; Bonomo P; Ferella L; D'Angelo E; Maddalo M; Alterio D; Infante G; Bacigalupo A; Argenone A; Iacovelli NA; Desideri I; Meduri B; Triggiani L; Volpe S; Belgioia L; Dionisi F; Romanello DA; Fallai C; Miceli R
    Head Neck; 2019 Oct; 41(10):3684-3692. PubMed ID: 31355972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility report for retreatment of locally recurrent head-and-neck cancers by combined brachy-chemotherapy using frameless image-guided 3D interstitial brachytherapy.
    Krempien RC; Grehn C; Haag C; Straulino A; Hensley FW; Kotrikova B; Hofele C; Debus J; Harms W
    Brachytherapy; 2005; 4(2):154-62. PubMed ID: 15893270
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Multi-institutional Comparison of SBRT and IMRT for Definitive Reirradiation of Recurrent or Second Primary Head and Neck Cancer.
    Vargo JA; Ward MC; Caudell JJ; Riaz N; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Higgins KA; Hassanadeh C; Beitler JJ; Reddy CA; Marcrom S; Boggs DH; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):595-605. PubMed ID: 28899556
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate.
    Strojan P; Corry J; Eisbruch A; Vermorken JB; Mendenhall WM; Lee AW; Haigentz M; Beitler JJ; de Bree R; Takes RP; Paleri V; Kelly CG; Genden EM; Bradford CR; Harrison LB; Rinaldo A; Ferlito A
    Head Neck; 2015 Jan; 37(1):134-50. PubMed ID: 24481720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brachytherapy after salvage surgery in cases with large isolated cervical recurrence of squamous cell carcinoma in the previously irradiated neck.
    Miroir J; Biau J; Saroul N; Moreira JF; Russier M; Lapeyre M
    Head Neck; 2016 Sep; 38(9):E2490-4. PubMed ID: 27061855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Carbon Ion Reirradiation for Recurrent Head and Neck Cancer: A Single-Institutional Experience.
    Held T; Windisch P; Akbaba S; Lang K; El Shafie R; Bernhardt D; Plinkert P; Kargus S; Rieken S; Herfarth K; Debus J; Adeberg S
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(4):803-811. PubMed ID: 31349059
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conformal re-irradiation of recurrent and new primary head-and-neck cancer.
    Dawson LA; Myers LL; Bradford CR; Chepeha DB; Hogikyan ND; Teknos TN; Terrell JE; Wolf GT; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):377-85. PubMed ID: 11380224
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What is the role of postoperative re-irradiation in recurrent and second primary squamous cell cancer of head and neck? A literature review according to PICO criteria.
    Merlotti A; Mazzola R; Alterio D; Alongi F; Bacigalupo A; Bonomo P; Maddalo M; Russi EG; Orlandi E
    Crit Rev Oncol Hematol; 2017 Mar; 111():20-30. PubMed ID: 28259292
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
    Sulman EP; Schwartz DL; Le TT; Ang KK; Morrison WH; Rosenthal DI; Ahamad A; Kies M; Glisson B; Weber R; Garden AS
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):399-409. PubMed ID: 18556144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Submandibular gland-sparing intensity modulated radiotherapy in the treatment of head and neck cancer: sites of locoregional relapse and survival.
    Collan J; Kapanen M; Mäkitie A; Nyman H; Joensuu H; Tenhunen M; Saarilahti K
    Acta Oncol; 2012 Jul; 51(6):735-42. PubMed ID: 22150115
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.
    Sher DJ; Haddad RI; Norris CM; Posner MR; Wirth LJ; Goguen LA; Annino D; Balboni T; Allen A; Tishler RB
    Cancer; 2010 Oct; 116(20):4761-8. PubMed ID: 20572036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Re-irradiation in head and neck cancers: an Indian tertiary cancer centre experience.
    Mallick S; Gandhi AK; Joshi NP; Pandit S; Bhasker S; Sharma A; Thakar A; Mohanti BK
    J Laryngol Otol; 2014 Nov; 128(11):996-1002. PubMed ID: 25316005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of recurrence after selective postoperative radiation therapy for patients with head and neck squamous cell carcinoma.
    Murakami N; Matsumoto F; Yoshimoto S; Ito Y; Mori T; Ueno T; Tuchida K; Kashihara T; Kobayashi K; Harada K; Kitaguchi M; Sekii S; Umezawa R; Takahashi K; Inaba K; Igaki H; Itami J
    BMC Cancer; 2016 Mar; 16():192. PubMed ID: 26951089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose-rate intraoperative brachytherapy and radical surgical resection in the management of recurrent head-and-neck cancer.
    Teckie S; Scala LM; Ho F; Wolden S; Chiu J; Cohen GN; Wong R; Ganly I; Zelefsky MJ; Lee NY
    Brachytherapy; 2013; 12(3):228-34. PubMed ID: 23466361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of concurrent carboplatin plus radiotherapy for locally advanced head and neck cancer patients ineligible for treatment with cisplatin.
    Hamauchi S; Yokota T; Onozawa Y; Ogawa H; Onoe T; Kamijo T; Iida Y; Nishimura T; Onitsuka T; Yasui H
    Jpn J Clin Oncol; 2015 Dec; 45(12):1116-21. PubMed ID: 26423341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized trial comparing two methods of re-irradiation after salvage surgery in head and neck squamous cell carcinoma: Once daily split-course radiotherapy with concomitant chemotherapy or twice daily radiotherapy with cetuximab.
    Tao Y; Faivre L; Laprie A; Boisselier P; Ferron C; Jung GM; Racadot S; Gery B; Even C; Breuskin I; Bourhis J; Janot F
    Radiother Oncol; 2018 Sep; 128(3):467-471. PubMed ID: 29784451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reirradiation of Head and Neck Cancers With Intensity Modulated Radiation Therapy: Outcomes and Analyses.
    Takiar V; Garden AS; Ma D; Morrison WH; Edson M; Zafereo ME; Gunn GB; Fuller CD; Beadle B; Frank SJ; William WN; Kies M; El-Naggar AK; Weber R; Rosenthal DI; Phan J
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1117-31. PubMed ID: 27354127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refining Patient Selection for Reirradiation of Head and Neck Squamous Carcinoma in the IMRT Era: A Multi-institution Cohort Study by the MIRI Collaborative.
    Ward MC; Riaz N; Caudell JJ; Dunlap NE; Isrow D; Zakem SJ; Dault J; Awan MJ; Vargo JA; Heron DE; Higgins KA; Beitler JJ; Marcrom S; Boggs DH; Hassanzadeh C; Reddy CA; Bonner JA; Yao M; Machtay M; Siddiqui F; Trotti AM; Lee NY; Koyfman SA;
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):586-594. PubMed ID: 28865925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-irradiation for recurrent and second primary cancers of the head and neck.
    Velez MA; Veruttipong D; Wang PC; Chin R; Beron P; Abemayor E; St John M; Chen AM
    Oral Oncol; 2017 Apr; 67():46-51. PubMed ID: 28351580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.